Vitamin D deficiency is common among patients with psychotic disorders and could be due to unknown disease mechanisms or contingent factors. However most studies are performed in chronic patients and have often failed to address the influence of ethnicity on vitamin D levels in clinical samples. We investigated serum concentrations of 25-hydroxy vitamin D (S-25 OH D) in first episode patients compared to patients with multi episodes and healthy controls; with a specific focus on differences between visible ethnic minorities and participants from the majority population. A total of 284 participants were included in this cross-sectional study. First episode patients with a DSM-IV psychotic disorder were matched on age, gender and ethnicity to participants from a multi episode patient sample (1:1) and healthy controls (1:2). We did not find any differences between either patient groups or the healthy controls, but participants from visible ethnic minorities had significantly lower S-25 OH D than participants from the majority population. This implies that S-25 OH D should be routinely measured in persons from visible ethnic minorities since low levels are associated with higher levels of depressive symptoms.
Introduction
The active metabolite of vitamin D is a steroid hormone with multiple functions. It binds to the vitamin D receptor (VDR) which is found in most parts of the body, including the immune system (Fernandes de Abreu et al., 2009 ) and the central nervous system (Stumpf, 2012) . Vitamin D is involved in the proliferation, differentiation and growth of neurons and has an important role in neuroplasticity (Deluca et al., 2013) both in the developing and adult brain.
Two recent meta-analyses have indicated significantly lower serum -25 hydroxy vitamin D (S-25 OH D) in patients with established psychiatric disorders compared to healthy controls (Belvederi Murri et al., 2013; Valipour et al., 2014) , in line with previous studies showing an association between lower S-25 OH D and having a diagnosis in the schizophrenia spectrum (Rey-Sanchez et al., 2009; Partti et al., 2010) . Correspondingly, in a study of diagnostically diverse psychiatric out-patients the lowest S-25 OH D levels were found in patients with schizophrenia or autism spectrum disorders (Humble et al., 2010) . There are thus relatively consistent indications of lower S-25 OH D in patients with psychotic disorders, especially schizophrenia. To what extent the low vitamin D levels are related to (hitherto unknown) disease mechanisms or secondary to poor nutrition, reduced self-care or medication use is not known. Most studies have included chronic patients, i.e. groups that probably will be more influenced by these types of contingent factors than patients with a recent onset of their disease.
However only two earlier studies have up to now been conducted in first episode/first treatment samples and their findings are equivocal. One study (N= 138) found significantly lower S-25 OH D in both white and black patients, but not in patients of Asian origin, compared to healthy controls (Crews et al., 2013) . The other small study (N= 40) did not find any patient/ control differences (Graham et al., 2014) .
The main source of vitamin D is ultraviolet B (UVB) radiation from the sun. Dark skin (high pigmentation), , body-covering clothing and reduced outdoor activities, will interact with available UVB radiation, dependent on geographical latitude and season of the year, in affecting vitamin D levels in the body (Wacker and Holick, 2013) . This is of interest for the study of psychotic disorders since there are consistent findings of a higher incidence of psychotic disorders in immigrants and visible ethnic minorities, in particular dark-skinned immigrants to countries with predominantly white majority populations, i.e. countries at high latitudes (Cantor-Graae and Selten, 2005) . There are however few studies of the associations between ethnic background and vitamin D levels in psychotic disorders. In the current clinical cross sectional study we thus aimed to explore differences in S-25 OH D between a first episode psychosis patient sample, compared to a multi-episode patient sample and a healthy control sample matched for age, gender and ethnic background. We 
Participants
A power analysis based on group differences (means and standard deviations) from the previous vitamin D in FEP study (Crews et al., 2013) indicated that a group size of 46 participants would be sufficient to detect real differences given the expected differences and standard deviations. A total of 71 first episode patients (FEP) with a DSM-IV psychotic disorder (Schizophrenia spectrum i.e. In the FEP and MEP groups total duration of illness (including treated and untreated phases) was measured in years and calculated as age minus age at onset. Current symptomatology was assessed by The Structured Interview for the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) .
At inclusion the participants went through a physical examination with blood sample withdrawal.
Height and weight were measured by a standard procedure, and BMI was calculated by kg/m².
Biochemical
In the TOP sample; 25-OH D (25-OH D2 and 25-OH D3) serum concentrations were determined using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method developed at the Hormone laboratory (Oslo University Hospital, Norway) (supplementary materials 1). In the Oslo Immigrant Health Study, S-25 OH D was measured by a radioimmunoassay (RIA kit from Diasorin) (Holvik et al., 2005) . The equation LC/MS-MS = 1.16 x (RIA) -9 was calibrated at the laboratory for comparisons and the calibrated values from the Oslo Immigrant Health Study are used in the current study.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics v. 22 (IBM corp. 2014) . The level of significance was preset to p < 0.05 (two tailed). Student t-tests and one way ANOVAs with Tukey post hoc tests were used for group comparisons of continuous variables, chi-square tests for categorical variables and Pearson's r for bivariate correlations. Normally distribution of the continuous variables was evaluated by normality plots and found to be satisfactory with the exception of the assessments of duration of untreated psychosis and total duration of illness where we used Spearman's correlations. For statistical purposes, season was dichotomized into winter (December -May) and summer (June-November) (Porojnicu et al., 2007) . For PANSS we used the five factor model by
Wallwork (Wallwork et al., 2012 
Results
The demographic and clinical sample characteristics are shown in table 1. Due to the matching procedure the age and gender by ethnicity distribution found in the FEP group were repeated in the MEP and in HC groups. The following variables differed between the groups: The MEP sample had significantly higher BMI than both FEP and HC with mean values slightly above upper limit of the normal range according to the WHO definition (range 18.5-24.9). The majority of HC had their blood samples taken during winter season. Concerning differences between the ethnic groups, there were a larger proportion of males in the visible minority group than in the majority group (80% vs 60%, p= 0.001).
There were no significant differences in unadjusted S-25 OH D between the FEP, MEP and HC. S-25
OH D was lower in males, in samples drawn during the winter season and in visible ethnic minorities (table 2) 
Discussion
In the current study we did not find any statistically significant differences in vitamin D status between a group of first episode patients, when compared to multi-episode patients and to healthy controls, respectively. There were however significant differences in S-25 OH D between participants from visible ethnic minorities and participants from the majority population.
This first finding is in contrast to earlier case-control studies including patients with established psychotic disorders (Rey-Sanchez et al., 2009; Partti et al., 2010; Itzhaky et al., 2012; Jamilian et al., 2013) . These previous studies however have methodological limitations, including lack of adjustment for ethnicity (Rey-Sanchez et al., 2009; Partti et al., 2010; Doknic et al., 2011; Jamilian et al., 2013) , comparison between hospitalized patients and health care workers (Itzhaky et al., 2012) or hospitalized patients and healthy controls recruited by advertisements without control for place of residence (Crews et al., 2013) . The healthy controls in the current study were randomly recruited from the same catchment area as the study patients and matched both for ethnicity and other important confounding variables such as gender and age. A review of reported vitamin D levels from these previous studies actually show remarkably similar vitamin D levels for the patient groups, but with considerable variations in the levels of the control groups. Our analyses underline this as we found larger seasonal variations in vitamin D levels in healthy controls than in the patient groups.
The current findings are also in contrast to a previous study from our group, that found lower S-25 OH D in a clinical patient sample compared to a population based control sample, both from the Norwegian population (Berg et al., 2010) . The main difference between the current study and the previous is that Berg used a control group where data on vitamin D, age and season for blood sampling were provided from a population study as means and standard deviations at group level.
The current study has control samples with individual data for each participant, thus enabling us to match directly on important background variables including age. Since psychotic disorders have onset in adolescence or early adulthood, clinical samples can often be younger than the healthy controls, and this is of importance since there is a possibility for an age gradient in S-25 OH D levels.
Since older and more chronic patient groups are more prone to be influenced by illness related lifestyle factors it is possible that investigations of this patient group will show differences between patients and controls independent of ethnic background. in Northern hemisphere (Holvik et al., 2005; Andersen et al., 2007) . People living in Norway have poor access to vitamin D from the sun, because of high latitude and long winter seasons (Wacker and Holick, 2013) . In the absence of sun exposure through winter, diet and supplements become all the more important, but natural sources are few (mainly fatty fish and cod liver oil). Thus, cultural differences in diet can be one of the reasons for alarmingly low S-25 OH D both in patients and healthy controls from visible ethnic minorities. Possibly, language barriers could also lead to a failure in reaching the ethnic minority population with advices regarding use of supplements. The finding that MEP from the visible ethnic minority group actually had higher S-25 OH D during winter than summer could indicate that health care workers aware of their heightened risk of vitamin D deficiency during the winter season actively encouraged their use of dietary supplements. Our analyses also showed that the S-25 OH D in healthy controls from the majority population varied more between winter and summer than in the corresponding patient groups. This could be explained by contingent factors such as reduced outdoor activities in the patient group during summer, compared to healthy controls.
This high proportion of patients with low S-25 OH D is of importance since this might influence morbidity both related to depressive (Berg et al., 2010) , positive (Yuksel et al., 2014) , negative (Graham et al., 2014) or atypical symptoms (Dealberto, 2013) . There were no significant correlations between S-25 OH D and positive or negative symptomatology in the current study, but there was a moderate association between low S-25 OH D and increased depressive symptomatology in the FEP group. Indications of an association between low S-25 OH D and depression has been shown previously, but should be investigated further in a larger samples because vitamin D substitution could represent a possible intervention strategy in persons from visible ethnic minorities. We would however need randomized controlled trials to evaluate the effect. Another point of importance is that the risk of cardiovascular diseases and metabolic syndrome has been found to be associated with psychotic disorders (Johnsen et al., 2011; Ringen et al., 2014) . Increased cardiovascular risk is also related to inadequate S-25 OH D levels (Choi et al., 2014; Menezes et al., 2014; Ruwanpathirana et al., 2014) . Elevated risk of cardiovascular disease and metabolic syndrome in psychotic disorder in visible ethnic minorities has been demonstrated in long-term follow-ups (Henderson et al., 2005) . It is thus of interest that, in our age and gender matched sample, visible ethnic minorities also had significantly higher BMI than the group recruited from the majority population, as well as lower S-25 OH D.
While we did not find any differences in S-25 OH D between adult patients with psychotic disorders and healthy controls, prospective studies have suggested vitamin D deficiency as a contributing factor to higher risk of developing psychotic disorders in dark skinned immigrants (McGrath, 1999; Dealberto, 2007; Kinney et al., 2009; McGrath, 2011) . There are also associations between vitamin D deficiency and known risk factors for psychotic disorders like urban living, winter births (Kendell and Adams, 2002) and migration (Dealberto, 2007) An important strength of the current study is that the patient sample consists of both in-and outpatients, and thus can be seen as more representative of patients in general compared to samples recruited from inpatients' wards only. A major limitation to the study is the use of ethnicity as a proxy for skin pigmentation, even if we did not find significant differences in , p = 0.03 
